Company Statement: Shire to establish new regenerative medicine business unit through cash acquisition of Advanced BioHealing, Inc., including US-marketed DERMAGRAFT
MLex Summary: Shire has announced its plans to purchase Advanced Biohealting for 750 million dollars cash. The companies expect the deal to close pending antitrust approval. Company press release follows in...To view the full article, register now.
Already a subscriber? Click here to view full article